Krystal Biotech, Inc.
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical…
Biotechnology
US, Pittsburgh [HQ]
Balance Sheet
8 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|
| Assets | 2.00 | 50.00 | 116.00 | 209.00 | 310.00 | 626.00 | 558.00 | 818.00 | |
|
Current
|
2.00 | 49.00 | 112.00 | 195.00 | 275.00 | 442.00 | 383.00 | 587.00 | |
| Cash And Equivalents | 1.00 | 49.00 | 103.00 | 187.00 | 268.00 | 341.00 | 161.00 | 358.00 | |
| Assets | 2.00 | 50.00 | 116.00 | 209.00 | 310.00 | 626.00 | 558.00 | 818.00 | |
| Accounts Receivables (AR) | - - | - - | - - | - - | - - | - - | - - | -42.00 | |
| Inventory | - - | - - | - - | - - | - - | - - | - - | 6.00 | |
| Short Term Investments | - - | - - | 8.00 | 6.00 | 2.00 | 96.00 | 217.00 | 173.00 | |
| Other Current Assets | - - | - - | - - | 2.00 | 3.00 | 4.00 | 4.00 | 6.00 | |
|
Non Current
|
- - | - - | 3.00 | 13.00 | 35.00 | 184.00 | 174.00 | 230.00 | |
| Property, Plant, Equipment (Net) | - - | - - | 3.00 | 11.00 | 34.00 | 119.00 | 169.00 | 168.00 | |
|
Intangible Assets
|
- - | - - | - - | - - | - - | - - | - - | - - | |
| Goodwill | - - | - - | - - | - - | - - | - - | - - | - - | |
| Long Term Investments | - - | - - | - - | - - | - - | 64.00 | 4.00 | 61.00 | |
| Other Non Current Assets | - - | - - | - - | 1.00 | 1.00 | - - | - - | - - | |
| Liabilities | 1.00 | - - | 2.00 | 6.00 | 18.00 | 32.00 | 36.00 | 39.00 | |
|
Current
|
- - | - - | 2.00 | 3.00 | 15.00 | 25.00 | 28.00 | 33.00 | |
| Accounts Payable | - - | - - | - - | - - | - - | - - | -1.00 | - - | |
| Short Term Debt | - - | - - | - - | - - | 8.00 | 1.00 | 1.00 | 1.00 | |
| Deferred Revenue | - - | - - | - - | 2.00 | 5.00 | 16.00 | - - | - - | |
| Tax Payable | - - | - - | - - | - - | - - | - - | - - | 2.00 | |
| Other Current Liabilities | - - | - - | 1.00 | - - | - - | - - | 23.00 | 27.00 | |
|
Non Current
|
1.00 | - - | - - | 2.00 | 3.00 | 6.00 | 7.00 | 6.00 | |
| Long Term Debt | 1.00 | - - | - - | 2.00 | 3.00 | 6.00 | 7.00 | 6.00 | |
| Leasing Obligations | - - | - - | - - | 3.00 | 11.00 | 8.00 | 8.00 | 6.00 | |
| Deferred Non Current Tax Liabilities | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Non Current Liabilities | - - | - - | - - | - - | - - | - - | - - | - - | |
| Equity | - - | 49.00 | 113.00 | 202.00 | 292.00 | 593.00 | 522.00 | 778.00 | |
| Stockholders' Equity | - - | 49.00 | 113.00 | 202.00 | 292.00 | 593.00 | 522.00 | 778.00 | |
| Retained Earnings | -1.00 | -9.00 | -19.00 | -39.00 | -71.00 | -140.00 | -280.00 | -269.00 | |
| Common Stock | - - | -50.00 | - - | - - | - - | - - | - - | - - | |
| Preferred Stock | 1.00 | 50.00 | 116.00 | - - | - - | - - | - - | - - | |
| Profit | -1.00 | -7.00 | -10.00 | -19.00 | -32.00 | -69.00 | -139.00 | 10.00 | |
| Dividends | - - | - - | - - | - - | - - | - - | - - | - - | |
| Minority Interest | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Stockholders' Equity | - - | 58.00 | 17.00 | 241.00 | 363.00 | 734.00 | 803.00 | 1,047.00 | |
| Loss Other Compr. Income | - - | - - | - - | - - | - - | - - | - - | - - |